Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20190826
    Release date: 19 November 2021

    Promoter – Financial Intermediary

    POCARED DIAGNOSTICS LTD

    Location

    Description

    Developing a real-time, high-volume, reagent-free in vitro diagnostics system for infectious diseases, with a focus on Antimicrobial Susceptibility Testing ("AST") and Antimicrobial Resistance ("AMR").

    Objectives

    The proposed transaction will support research and development (R&D) investments required to bring products to the market addressing high unmet medical needs, in a growing patient population, preserving and cultivating highly skilled employment opportunities.

    Sector(s)

    • Services - Professional, scientific and technical activities

    Proposed EIB finance (Approximate amount)

    EUR 22 million

    Total cost (Approximate amount)

    EUR 46 million

    Environmental aspects

    The project mainly concerns investments in research and development (R&D) that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2014/52/EU amending the Directive 2011/92/EC.

    Procurement

    The Promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; thus the project is not covered by the EU directives on procurement. However, the Promoter's procurement procedures are expected to be in line with EIB guidelines for private sector projects.

    Status

    Under appraisal - 19/11/2021

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    Israel Services